Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION).
Michael J. Morris, Johann S. De Bono,Kim N. Chi,Karim Fizazi,Ken Herrmann,Kambiz Rahbar,Scott T. Tagawa,Luke T. Nordquist,Nitin Vaishampayan,Ghassan El-Haddad,Chandler H. Park,Tomasz M. Beer,Wendy J. Perez-Contreras,Michelle Desilvio, Euloge E. Kpamegan,Germo Gericke,Richard Adam Messmann,Bernd J. Krause,A. Oliver Sartor JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
